Ghent University Academic Bibliography

Journal Article
A1
open access

Variable and fixed costs in NHS radiotherapy : consequences for increasing hypo fractionation

Katie Spencer, Noemie Defourny, David Tunstall, Viv Cosgrove, Karen Kirkby, Ann Henry, Yolande Lievens (UGent) and Peter Hall

(2022) RADIOTHERAPY AND ONCOLOGY. 166. p.180-188

Add to list

Journal Article
A1
open access

Innovation, value and reimbursement in radiation and complex surgical oncology : time to rethink

Josep M. Borras, Julieta Corral, Ajay Aggarwal, Riccardo Audisio, Josep Alfons Espinas, Josep Figueras, Peter Naredi, Dimitra Panteli, Nicolas Pourel, Joan Prades, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 169. p.114-123

Add to list

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Sarah L. Kerns, Ashley Amidon Morlang, Sharon M. Lee, Derick R. Peterson, Brian Marples, Hong Zhang, Kevin Bylund, Doug Rosenzweig, William Hall, Kim De Ruyck (UGent) , et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 168. p.75-82

Add to list

Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature

Willeke Danckaert (UGent) , Mathieu Spaas (UGent) , Katrien Vandecasteele (UGent) , Carlos De Wagter (UGent) and Piet Ost (UGent)

(2022) RADIOTHERAPY AND ONCOLOGY. 170. p.64-69

Add to list

Journal Article
A1
open access

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer

Sofia C. Vaz, Judit A. Adam, Roberto C. Delgado Bolton, Pierre Vera, Wouter van Elmpt, Ken Herrmann, Rodney J. Hicks, Yolande Lievens (UGent) , Andrea Santos, Heiko Schöder, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 168. p.37-39

Add to list

Journal Article
A1
open access

Letter to the editor concerning Offersen et al., [Radiother Oncol 2015; 114: 3-10]

Michael Stouthandel (UGent) , Liv Veldeman (UGent) and Tom Van Hoof (UGent)

(2021) RADIOTHERAPY AND ONCOLOGY. 154. p.135-136

Add to list

Journal Article
A1
open access

Hypofractionated radiotherapy in the real-world setting : an international ESTRO- GIRO survey

D. Rodin, B. Tawk, O. Mohamad, S. Grover, F.Y. Moraes, M.L. Yap, E. Zubizarreta and Yolande Lievens (UGent)

(2021) RADIOTHERAPY AND ONCOLOGY. 157. p.32-39

Add to list

Journal Article
A1
open access

Value-based radiotherapy : a new chapter of the ESTRO-HERO project

Yolande Lievens (UGent) , Josep-Maria Borras, Cai Grau and Ajay Aggarwal

(2021) RADIOTHERAPY AND ONCOLOGY. 160. p.236-239

Add to list

Journal Article
A1
open access

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Nicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, Andrea Manzoni, Anna Maria Paganoni, Paolo Zunino, Liv Veldeman (UGent) , Piet Ost (UGent) , Valerie Fonteyne (UGent) , Christopher J. Talbot, et al.

(2021) RADIOTHERAPY AND ONCOLOGY. 159. p.241-248

Add to list

Journal Article
A1
open access

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

B.G. Wortman, E. Astreinidou, M.S. Laman, E.M. van der Steen-Banasik, L.C.H.W. Lutgens, H. Westerveld, F. Koppe, A. Slot, H.A. van den Berg, M.E. Nowee, et al.

(2021) RADIOTHERAPY AND ONCOLOGY. 155. p.160-166

Academic Bibliography

Variable and fixed costs in NHS radiotherapy : consequences for increasing hypo fractionation

Innovation, value and reimbursement in radiation and complex surgical oncology : time to rethink

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer

Letter to the editor concerning Offersen et al., [Radiother Oncol 2015; 114: 3-10]

Hypofractionated radiotherapy in the real-world setting : an international ESTRO- GIRO survey

Value-based radiotherapy : a new chapter of the ESTRO-HERO project

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

Contents

Support

Contact